| Literature DB >> 28905052 |
Cristina N Alexandru-Crivac1, Christian Umeobika2, Niina Leikoski3, Jouni Jokela3, Kirstie A Rickaby2, André M Grilo1, Peter Sjö4, Alleyn T Plowright5, Mohannad Idress1, Eike Siebs2, Ada Nneoyi-Egbe2, Matti Wahlsten3, Kaarina Sivonen3, Marcel Jaspars2, Laurent Trembleau2, David P Fewer3, Wael E Houssen6.
Abstract
Macrocyclic peptides have promising therapeutic potential but the scaling up of their chemical synthesis is challenging. The cyanobactin macrocyclase PatGmac is an efficient tool for production but is limited to substrates containing 6-11 amino acids and at least one thiazoline or proline. Here we report a new cyanobactin macrocyclase that can cyclize longer peptide substrates and those not containing proline/thiazoline and thus allows exploring a wider chemical diversity.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28905052 DOI: 10.1039/c7cc05913b
Source DB: PubMed Journal: Chem Commun (Camb) ISSN: 1359-7345 Impact factor: 6.222